Clinical Trials · NCT04878393
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 650
- Start date
- Apr 2021
- Locations
- 1 site, Japan
- Primary endpoint
- Change in glycated haemoglobin (HbA1c)